Your browser doesn't support javascript.
loading
Cost of Treating Acute Promyelocytic Leukemia (APL) Patients in Italy.
Kruse, M M; Wildner, R; Barnes, G; Martin, M; Mueller, U; Lo Coco, F; Leyman, S; Pathak, A.
  • Kruse MM; Optum, Waltham, MA, USA.
  • Wildner R; Optum, Waltham, MA, USA.
  • Barnes G; Teva Pharmaceutical, 19355, PA, USA.
  • Martin M; OptumInsight, Uxbridge, Middlesex, UK.
  • Mueller U; Teva Pharmaceutical, Ehrenkirchen, Germany.
  • Lo Coco F; University Tor Vergata, Rome, PA, USA.
  • Leyman S; TEVA Pharmaceuticals Europe, Amsterdam, The Netherlands.
  • Pathak A; Teva Pharmaceutical, 19355, PA, USA.
Value Health ; 17(7): A624, 2014 Nov.
Article en En | MEDLINE | ID: mdl-27202202
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Health_economic_evaluation Idioma: En Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Health_economic_evaluation Idioma: En Año: 2014 Tipo del documento: Article